Fig. 12From: Identification and validation of an individualized metabolic prognostic signature for predicting the biochemical recurrence of prostate cancer based on the immune microenvironmentExpression analysis of prognostic MTGs in PCa. A The differential expression of CEL, PDE6G, and CYP3A4 in PCa tissue from the TCGA database. B The relative expression of CEL, PDE6G, and CYP3A4 in prostate cell lines from the CCLE database. C The relative expression of CEL, PDE6G, and CYP3A4 in prostate cell lines was determined via RT‒PCRBack to article page